Stock data
Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. (TCRT) reported revenue of US$0.01M and net income of -US$4.18M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.01M | — | -US$4.22M | -US$4.18M | — |
| 2024 | US$0.01M | — | -US$4.81M | -US$4.68M | — |
| 2023 | US$0.01M | — | -US$34.27M | -US$4.68M | — |
| 2022 | US$2.92M | — | -US$35.10M | -US$37.73M | — |
| 2021 | US$0.40M | — | -US$77.55M | -US$78.75M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$0.95M | — |
| 2026-03-31 | US$0.00M | -US$1.01M | — |
| 2025-12-31 | US$0.00M | -US$0.89M | — |
| 2025-09-30 | US$0.00M | -US$1.16M | — |
| 2025-06-30 | US$0.00M | -US$1.05M | — |
| 2025-03-31 | US$0.00M | -US$1.07M | — |
| 2024-12-31 | US$0.01M | -US$0.74M | — |
| 2024-09-30 | US$0.00M | -US$1.13M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.